Trademark: 90237013
Word
TASMAN PHARMA
Status Date
Tuesday, May 28, 2024
Filing Date
Tuesday, October 6, 2020
Published for Opposition
Tuesday, April 13, 2021
5 Pharmaceutical preparations for the prevention and treatment of psychiatric diseases and disorders, and oncological diseases and disorders
TASMAN PHARMACEUTICAL
"PHARMA"
Nov 19, 2020
New Application Office Supplied Data Entered
Oct 9, 2020
New Application Entered
Mar 5, 2021
Assigned To Examiner
Mar 9, 2021
Approved For Pub - Principal Register
Mar 24, 2021
Notification Of Notice Of Publication E-Mailed
Apr 13, 2021
Published For Opposition
Apr 13, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 8, 2021
Noa E-Mailed - Sou Required From Applicant
Nov 22, 2021
Sou Teas Extension Received
Nov 22, 2021
Sou Extension 1 Filed
Nov 22, 2021
Sou Extension 1 Granted
Nov 24, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 7, 2022
Sou Extension 3 Filed
Jun 3, 2022
Sou Teas Extension Received
Jun 3, 2022
Sou Extension 2 Filed
Jun 3, 2022
Sou Extension 2 Granted
Jun 7, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 7, 2022
Sou Teas Extension Received
Dec 7, 2022
Sou Extension 3 Granted
Dec 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 6, 2023
Sou Teas Extension Received
Jun 6, 2023
Sou Extension 4 Filed
Jun 6, 2023
Sou Extension 4 Granted
Jun 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 4, 2023
Sou Extension 5 Filed
Dec 14, 2023
Sou Extension 5 Granted
Dec 4, 2023
Sou Teas Extension Received
Dec 13, 2023
Case Assigned To Intent To Use Paralegal
May 27, 2024
Use Amendment Filed
May 27, 2024
Teas Statement Of Use Received
May 28, 2024
Statement Of Use Processing Complete
Dec 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
